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Abstract
We estimated the prevalence of obesity, overweight, and underweight among US adolescents with 
and without autism and other learning and behavioral developmental disabilities (DDs) and 
assessed the health consequences of obesity among adolescents with DDs. From the 2008 to 2010 
National Health Interview Survey, we selected 9,619 adolescents ages 12–17 years. Parent 
respondents reported weight, height, presence of DDs and health conditions. We calculated body 
Correspondence to: Laura A. Schieve.
HHS Public Access
Author manuscript
Matern Child Health J. Author manuscript; available in PMC 2017 February 27.
Published in final edited form as:
Matern Child Health J. 2014 October ; 18(8): 1964–1975. doi:10.1007/s10995-014-1442-y.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
mass index (BMI) and defined obesity, overweight, and underweight as ≥95th, ≥85th to <95th, and 
<5th percentiles, respectively, using established criteria. We created mutually-exclusive DD 
subgroups using the following order of precedence: autism; intellectual disability; attention-
deficit-hyper-activity-disorder; learning disorder/other developmental delay. We compared BMI 
outcomes among adolescents in each DD group versus adolescents without DDs using 
multivariable logistic regression. Socio-demographic factors and birthweight were included as 
confounders. Estimates were weighted to reflect the US population. Both obesity and underweight 
prevalences were higher among adolescents with than without DDs [adjusted prevalence ratios 
(aPR) 1.5 (1.25–1.75) and 1.5 (1.01–2.20), respectively]. Obesity was elevated among adolescents 
with all DD types, and was highest among the autism subgroup [aPR 2.1 (1.44–3.16)]. 
Adolescents with either a DD or obesity had higher prevalences of common respiratory, 
gastrointestinal, dermatological and neurological conditions/symptoms than nonobese adolescents 
without DDs. Adolescents with both DDs and obesity had the highest estimates for most 
conditions. Obesity is high among adolescents with autism and other DDs and poses added 
chronic health risks. Obesity prevention and management approaches for this vulnerable 
population subgroup need further consideration.
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Introduction
Obesity is estimated as 20 % among US children aged 6–17 years [1]. While some studies 
suggest even higher estimates in children with developmental disabilities (DDs) [2–5], they 
were limited in that DDs were either generally defined (i.e. by combining DDs with 
differing functional impacts as a single entity) [2, 3, 6–8] or the focus was limited to a single 
condition such as autism [5] or attention deficit disorder/attention deficit hyperactivity 
disorder (ADD/ADHD) [4]. Moreover, none accounted for the fact that many children are 
diagnosed with multiple DDs.
Additionally, the prevalence of underweight has not been well studied among children with 
DDs; nor have studies investigated the full body mass index (BMI) range more generally 
among children with DDs. While only 3.7 % of US children are underweight [9], children 
with DDs are potentially at higher risk for underweight because of dietary restrictions 
imposed in response to concurrent food allergies or as a potential treatment for behavioral 
symptoms, dietary aversions among children with some DDs, the potential for appetite 
suppression associated with some psychoactive medications, and gastrointestinal 
disturbances associated with DDs.
In this study, we provide nationally-representative estimates of obesity, overweight, and 
underweight among adolescent children with and without several specific learning and 
behavioral DDs. We examine both the risk factors for obesity and the health consequences of 
having obesity for adolescents with DDs compared to adolescents without DDs.
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Methods
Data Source
The NHIS is an annual in-person health survey of the civilian non-institutionalized US 
population [10]. The multistage sample design is based on household as the primary 
sampling unit. Within sampled households, one randomly-selected adult is asked to 
complete a family demographic survey and an individual adult health survey. In households 
with children, one child is additionally randomly sampled and a knowledgeable adult 
household member, usually a parent (92 %), is asked to complete a health survey about the 
child. For the current study, we used data from the 2008 to 2010 child and family surveys.
Study Population
Our analysis included 9,619 adolescents aged 12–17 years. We necessarily limited our 
sample to this age range because height and weight data were not collected for younger 
children [11].
Developmental Disability Definitions
We analyzed children with and without DDs associated with learning and behavior: autism, 
intellectual disability (ID), ADD/ADHD, learning disability (LD), and other developmental 
delay. Autism, ID, ADD/ADHD, and other developmental delay were ascertained with the 
following question format: “Has a doctor or health professional ever told you that [CHILD] 
had [CONDITION]?” LD was ascertained from a slightly different question: “Has a 
representative from a school or a health professional ever told you that [CHILD] had a 
learning disability?” Although the NHIS uses the term “mental retardation”, we 
synonymously use the more current term “intellectual disability” in this paper. As a subtype 
of the overarching disorder of ADHD, ADD was subsumed under the term “ADHD” for 
ease of presentation.
We created two general analytic groups: (1) adolescents without learning and behavioral 
DDs as our comparison group and (2) adolescents with any of the aforementioned DDs. We 
also sub-divided the DD group into four mutually-exclusive groups using the following 
order of precedence for adolescents with more than one DD diagnosis: (1) autism, (2) ID 
without autism, (3) ADHD without autism or ID (4) LD or other developmental delay 
without autism, ID, or ADHD. This order of precedence was chosen such that ADHD and 
LD could be examined without the co-occurring effects of the generally more pervasive 
DDs, autism and ID. Sample size constraints precluded further subdivisions of the autism 
and ID groups.
BMI Outcomes
Parents reported adolescents’ current height and weight. These data were used to compute 
BMI and BMI national percentile rankings for sex and age groups based on established CDC 
criteria [12, 13]. Obesity was defined as BMI ≥95th percentile; overweight was BMI of 85th 
to <95th percentile; healthy weight was BMI of 5th to<85th percentile; and underweight was 
BMI <5th percentile.
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Demographics
We assessed the following as potential confounders and obesity risk factors: child sex, low 
birth weight (LBW) (<2,500 g), age (12–14 vs. 15–17 years), race-ethnicity (non-Hispanic 
White (NHW), non-Hispanic Black (NHB), Hispanic, Asian, American Indians/Native 
American, and other), health insurance (insured vs. uninsured), poverty-to-income ratio 
(derived based on family income in relation to US Census Bureau poverty thresholds, <200 
vs. ≥200 %), and maternal education (≤high school vs. >high school) [11, 14, 15].
Concurrent Medical Conditions
We reviewed current literature on medical conditions associated with either childhood 
obesity or the presence of a DD [6, 8, 16–27]. Based on that review and our sample size, we 
examined parent report of the general occurrence of asthma; the recent (past 12 months) 
occurrence of respiratory allergy, food allergy, eczema/skin allergy, and headaches/
migraines; and the very recent (past 2 weeks) occurrence of stomach/intestinal illness and 
head/chest cold.
Statistical Analysis
We estimated percentage distributions for demographic characteristics among adolescents 
with and without any of the aforementioned DDs and adolescents within each of the DD-
specific subgroups and assessed differences with Chi square tests.
Within each analytic DD group, we estimated the prevalence of each BMI outcome outside 
the healthy range. We computed prevalence ratios and 95 % confidence intervals that 
compared BMI estimates for adolescents with each DD type to estimates for adolescents 
without DDs. We additionally conducted stratum-specific assessments based on child’s sex, 
age, race-ethnicity, and birthweight. The stratum-specific data informed the creation of 
logistic regression models to estimate adjusted prevalence ratios (PRs) for associations 
between each DD type and each BMI outcome. In these models, we included each variable 
assessed in stratified analyses and health insurance and maternal education as potential 
confounders. We did not include interaction terms because stratum-specific variation was 
fairly minimal.
Based on our initial findings, we conducted additional analyses for the obesity outcome. We 
assessed risk factors for obesity within each of the DD and DD subgroups of adolescents 
using multivariable logistic regression models. Potential risk factors were the same factors 
considered as potential confounders in the previous models.
Finally, we examined the prevalence of concurrent health conditions among four groups of 
adolescents: non-obese/no DDs; obese/no DDs; non-obese/one or more DDs; obese/one or 
more DDs. We compared adolescents in each of these groups and thus generated 4 sets of 
adjusted PRs. A previous analysis of these data indicated that children with these DDs were 
at increased risk for many concurrent health conditions compared to children without DDs 
[27]. Here we examined whether obesity was associated with an added health impact beyond 
the impact from obesity alone or having a DD alone.
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All but one set of estimates in this study were weighted to adjust for non-response and 
unequal selection probabilities and thus, produce estimates reflective of the US non-
institutionalized population of children ages 12–17 years; additionally, analyses were 
conducted using SUDAAN (version 9.0) software to account for the complex sampling 
design in variance estimation [28]. We assessed the total BMI distributions for adolescents 
with and without DDs using an unweighted sample and statistically compared these 
distributions with the Kolmogorov–Smirnov test for equality of distribution functions.
Human subjects review was not required for this study since this was a secondary analysis of 
de-identified datasets.
Results
Characteristics of Study Population
Our final study population included 1,478 adolescents who had one or more learning/
behavioral DDs and 8,141 adolescents without any of these DDs. We estimated the 
prevalence of any DDs among US adolescents as 15.4 %. DD-specific prevalence estimates 
were 0.6 % for ID without autism, 1 % for autism, 3.9 % for LD and other DDs without 
ADHD, autism, and ID, and 8.9 % for ADHD without autism and ID.
Adolescents with any DD were more likely to be male than adolescents without DDs; the 
proportion ranged among specific DDs from 59 % (ID group) to 80 % (autism group) (Table 
1). Age distributions were similar for adolescents with and without DDs. Adolescents with 
DDs were more likely to be NHW and have health insurance than adolescents without DDs, 
but they were also more likely to be from a low-income family. While the proportion of 
adolescents whose mothers were educated beyond high school was similar for adolescents 
with and without DDs (61 % for both), advanced maternal education varied widely for 
specific DDs, from 46 % (ID group) to 71 % (autism group). History of LBW was higher in 
adolescents with than without DDs, with the exception of autism.
Prevalence of Obesity, Overweight, and Underweight
The prevalence of obesity in adolescents with any DD was 20.4 % compared to 13.1 % of 
adolescents without DDs (Table 2). This 60 % differential was statistically significant and 
remained significant after adjustment for confounders. Among adolescents with DDs, those 
with autism had the highest obesity prevalence (31.8 %), while those with in the ADHD 
group had the lowest prevalence (17.6 %).
The prevalence of overweight for adolescents with any DD was 17.5 % which was similar to 
the prevalence in adolescents without DDs. Variation across DDs was minimal with no 
significant differences.
The prevalence of underweight for adolescents with any DD was 5.6 % compared to 3.5 % 
for adolescents without DDs. This 60 % differential remained significant after adjustment 
for potential confounders. While the prevalence of underweight was elevated for adolescents 
in all four DD groups, the increase was particularly notable among adolescents in the ID 
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group who had a fourfold higher prevalence. However, this difference was greatly reduced 
after adjustment for confounders; LBW was found to be a particularly impactful confounder.
The overall BMI distribution for adolescents in each of the four DD groups was wider than 
that for adolescents without DDs (Fig. 1). These differences were statistically significant, 
with the exception of the ID group (which was limited by small sample size). While the 
median BMIs varied only slightly across groups of adolescents with and without DDs, 
adolescents with DDs were less likely to have a BMI near their group’s median.
Supplemental Analyses of Underweight and Obesity Status by Prescription Medication 
Use
Because many psychoactive medications might be associated with child appetite and 
metabolism, we repeated prevalence analyses for adolescents with the two most commonly 
reported DDs, ADHD and LD/other developmental delay, after stratifying by recent 
prescription medication use. Among adolescents with both DD types, obesity was 
significantly increased only for those adolescents NOT taking prescription medications [aPR 
1.6 (1.2–2.1) for the ADHD group and aPR 1.9 (1.3–2.7) for the LD/other developmental 
delay group]. Additionally, adolescents with these DDs who were taking prescription 
medications tended to have a higher prevalence of underweight than adolescents without 
DDs; however, these findings did not reach statistical significance (data not shown). We 
were unable to study these medication subsets in children with autism or ID because of 
sample size constraints.
Risk Factors for Obesity
The obesity risk factor profile among adolescents without DDs was different than the profile 
for adolescents with DDs (Table 3). Among adolescents without DDs, obesity was higher in 
boys than girls and among adolescents 12–14 versus 15–17 years of age. Neither sex nor age 
were risk factors for obesity among adolescents with DDs. Additionally, LBW was 
associated with a twofold increase in obesity among adolescents in two DD groups (autism 
and ID without autism) but was not associated with obesity among adolescents without DDs. 
(However the association for the ID group approached but did not reach statistical 
significance.)
The three risk factors related to socioeconomic status, race-ethnicity, maternal education, 
and poverty-to-income ratio, were associated with obesity among adolescents both with and 
without DDs, but the specific factors associated with obesity within each group and 
subgroup varied.
Concurrent Health Conditions
Non-obese adolescents without DDs had the lowest prevalence estimates for most health 
conditions assessed, while obese adolescents with DDs had the highest estimates (Fig. 2). 
Obesity in the absence of a DD was associated with asthma, eczema, and frequent severe 
headaches/migraines (Table 4). Having a DD in the absence of obesity was associated with 
all of the aforementioned conditions and also respiratory allergy and very recent intestinal 
illness. Additionally, among adolescents with DDs, being obese conferred an additional risk 
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for several conditions. Obese adolescents with DDs had a 50 % higher asthma prevalence 
than non-obese adolescents with DDs. Likewise, adolescents with both a DD and obesity 
had 30–40 % higher prevalences of respiratory allergy, eczema/skin allergy, and frequent 
severe headaches/migraines than adolescents with a DD but not obesity; however, the 
confidence intervals for the adjusted PRs slightly overlapped 1.0.
Discussion
Underweight and Obesity Prevalence
This population-based study indicates that US adolescents with learning and behavioral DDs 
are 60 % more likely to be obese and also 60 % more likely to be underweight than 
adolescents without DDs.
We found that 31.8 % of adolescents with autism were obese, more than twice the 
prevalence observed for adolescents without DDs. Two previous studies of US children with 
autism that assessed the 2003 National Survey of Children’s Health (NSCH) reported 
obesity estimates of 30.4 % for children 3–17 years of age and 21.1 % for children 10–17 
years of age [3, 5]. The differences in estimates from our study and previous studies might 
partially reflect differences in the survey time periods.
The explanation for the autism-obesity association cannot be examined in this study. 
Previous studies reported that children with autism have overly selective or idiosyncratic 
food preferences [7, 29, 30] and that some children with autism tend to solely eat highly 
caloric foods and foods that are high in sugar content [31, 32]. A recent study reported that 
adolescents with autism have decreased levels of moderate to vigorous physical activity and 
have increased sedentary activity compared to their peers without autism [33]. While we 
observed a twofold-higher obesity prevalence among adolescents with autism than without 
DDs, we did not observe a prevalence differential for overweight. In fact, in contrast to our 
sample of children without DDs, children with autism had a higher prevalence of obesity 
(31.8 %) than overweight (20.9 %). A similar pattern was observed for children with ID, but 
not for children in the other DD groups. While we can only speculate on the reason for this 
unusual pattern of obesity versus overweight, the increased obesity risk among children with 
autism might be driven by marked differences in dietary and physical activity patterns 
among the subset with the most severe developmental functional limitations. Additionally, 
previous studies indicate a substantial proportion of individuals with autism and ID receive 
various psychotropic medications, with weight gain and increased appetites as common 
untoward side effects [34, 35]. These effects might be more likely to lead to obesity than 
overweight. We were unable to evaluate the impact of prescription drug use on BMI in our 
samples of children with autism and ID.
Our findings for adolescents with ID without autism must be interpreted cautiously due to 
sample size constraints. Nonetheless, our estimates generally inform the sparse literature for 
this subgroup and suggest that prevalence of both obesity and underweight might be elevated 
among children with ID. To date, most studies examining obesity and ID have been in adult 
samples comparing institutionalized and non-institutionalized persons and suggest that low 
income and associated environmental factors have considerable impacts on caloric intake 
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and physical activity among persons with ID [31, 36]. Studies also report that children with 
ID have significantly higher rates of poverty, are more physically inactive, and play less 
often with other children than children without DDs [3, 32, 37, 38].
Our initial finding of a 20–30 % increased prevalence of obesity among adolescents with 
ADHD and LD/other developmental delay was limited to adolescents who were NOT taking 
prescription medications. In this subset, obesity was 60–90 % higher than the rate observed 
among adolescents without DDs. These findings are comparable to the findings reported by 
previous studies [3, 39]. Studies have also reported that children with ADHD have difficulty 
with self-regulation, low physical activity, low gross motor performance, and delayed motor 
development, which might contribute to their obesity risk [40].
One previous study suggested an increase in underweight among those children with ADHD 
who were taking prescription medications [39]. While we also observed a higher prevalence 
of underweight in this subset of children with ADHD, the estimate was imprecise.
In addition to increased obesity prevalence among adolescents with DDs, we also observed 
variation in obesity risk factors among adolescents with and without DDs. While race-
ethnicity and SES indicators were associated with obesity in both adolescents with and 
without DDs, the specific race-ethnicity groups associated with higher obesity risk varied 
across DDs. Additionally, age and sex were associated with obesity only among adolescents 
without DDs. LBW was associated with obesity only among adolescents with DDs. We 
lacked data to explore this DD-specific LBW association further.
Data on obesity risk factors among children with DDs has been limited. Our findings among 
adolescents without DDs generally match previous studies that report higher levels of 
obesity in NHB and Hispanic adolescents than NHW adolescents [41–44], in adolescent 
males than females [41], and in children living in families with lower than higher household 
incomes [7]. Additionally, a recent meta-analysis indicated no association between obesity 
and LBW in children generally [45].
Obesity and DD Co-morbidity and Health Consequences
Our assessment of concurrent health conditions in relation to both obesity and DD statuses, 
expands on a previous report by our group that documented higher prevalence of common 
respiratory, gastrointestinal, dermatological and neurological health conditions among 
children with DDs than children without DDs [27]. Here, we document that the prevalence 
of these concurrent medical conditions is additionally impacted by obesity such that 
adolescents who had either a learning or behavioral DD or were obese had higher estimates 
for nearly every health condition included in this analysis than non-obese adolescents 
without DDs. For nearly all conditions assessed, the highest estimates were observed for 
adolescents with both obesity and a DD.
These findings are supported by previous studies of health consequences of obesity among 
children with DDs [3, 6, 8, 17], although Yamaki et al. [8] did not distinguish in their study 
between obesity and overweight. Studies have also shown associations between increased 
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BMI and asthma risk among children generally [23, 46, 47]. Obesity not only increases risk 
of asthma but has been observed to also interfere with optimal asthma management [23].
Limitations and Strengths
Interpretation of our findings should include consideration of potential limitations. Because 
NHIS data are cross-sectional, our ability to assess temporality and infer causal pathways 
between DDs, BMI, and various health conditions was limited. All health conditions and 
DDs were based on parent report and not verified clinically. BMI estimates were not based 
on direct measurement and thus should not be considered the US population gold standard. 
Because children with DDs may use more health care, they might be weighed and measured 
slightly more frequently than children without DDs, which could possibly impact parental 
recall. We have no other reason to believe that parental height and weight reporting was 
differential between adolescents with and without DDs. A previous study comparing parent-
reported weight and height estimates from national surveys, including NHIS, to measured 
estimates from NHANES found that the relative differences in parent-reported versus 
measured estimates of mean height were very small (<2 %) among all adolescents as were 
the relative differences in mean weight for adolescent males; relative differences in mean 
weight for adolescent females were slightly larger (4–6 % depending on age) and suggestive 
of under-reporting [44]. Thus, obesity rates reported here might have been slightly 
attenuated among females. We lacked data on dietary intake, physical activity levels, and 
family history of obesity. However for a portion of our sample (33 %), maternal BMI was 
available from a supplemental adult health survey. Limited analyses of this subsample 
suggests that our findings of associations between DD status and obesity and underweight 
prevalence were independent of maternal BMI, as were our findings about obesity risk 
factors (data not shown). While we were able to examine the DD-BMI outcome 
relationships by prescription medication use generally, we lacked data on specific 
psychoactive medications. Lastly, NHIS samples do not include institutionalized children, 
and thus a small percentage of children with the most severe DDs might not be represented 
in our analysis.
Despite the limitations, this analysis includes a recent and comprehensive assessment of 
BMI status, risk factors, and potential health consequences of obesity among US adolescents 
with learning and behavioral DDs. To our knowledge, no other US study specifically 
examined the full range of the BMI distribution in children with these DDs; nor did other 
studies to date consider the co-occurrence of DDs. The NHIS sample afforded us the 
opportunity to create mutually-exclusive DD groups, and thus examine DDs such as ADHD 
and LD independently from autism and ID, which are typically more pervasive.
Conclusion
Obesity poses significant chronic health risks within an already vulnerable population of 
adolescents with DDs. Current prevention strategies to combat childhood obesity may not be 
appropriate for all families of children with DDs. Most reports emphasize the importance of 
physical activity and recommend activities [17] which may or may not be appropriate for 
children and adolescents with DDs. Population-specific approaches have been proposed for 
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subgroups such as infants, toddlers, school-age children and adolescents, and children in 
ethnic minority populations, but currently, there are no specific recommendations for 
children or adolescents with DDs [17]. Obesity prevention and management approaches for 
this at-risk group thus needs further consideration. Although the prevalence of underweight 
was much lower than obesity, our finding of a potential increased risk for underweight 
among children with DDs, is also in need of further investigation to understand the 
underlying causes and possible prevention strategies.
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Fig. 1. 
Body mass index distributions of adolescents 12–17 years of age with and without 
developmental disabilities, NHIS 2008–2010. *Statistical significance is based on 
comparison of distribution curves (a–e) to distribution curve (f) using the Kolmogorov–
Smirnov test P value
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Fig. 2. 
Percentages of concurrent medical conditions among non-obese and obese adolescents 12–
17 years of age with and without developmental disabilities, NHIS 2008–2010. ┤: Displays 
error bars for the percent using standard error
Phillips et al. Page 14
Matern Child Health J. Author manuscript; available in PMC 2017 February 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Phillips et al. Page 15
Ta
bl
e 
1
D
em
og
ra
ph
ic
s o
f c
hi
ld
re
n 
w
ith
 d
ev
el
op
m
en
ta
l d
isa
bi
lit
ie
s a
m
on
g 
U
S 
ad
ol
es
ce
nt
s 1
2–
17
 y
ea
rs
 o
f a
ge
, N
H
IS
, 2
00
8–
20
10
C
hi
ld
re
n
 w
ith
ou
t 
de
v
el
op
m
en
ta
l 
di
sa
bi
lit
ie
s (
N 
= 8
,14
1)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 a
ny
 
le
ar
n
in
g 
an
d 
be
ha
v
io
ra
l d
isa
bi
lit
y 
(N
 = 
1,4
78
)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 
a
u
tis
m
 (N
 = 
93
)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 
in
te
lle
ct
ua
l d
isa
bi
lit
y 
(ID
) w
ith
ou
t a
ut
ism
 (N
 
=
 6
0)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 A
D
H
D
 
w
ith
ou
t a
ut
ism
/ID
 (N
 
=
 8
45
)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 L
D
/
o
th
er
 D
D
 w
ith
ou
t 
A
D
H
D
/a
ut
ism
/ID
 (N
 = 
37
6)
%
 (S
E)
Se
x
 
M
al
e
47
.0
 (0
.7)
67
.5
 (1
.4)
a
79
.7
 (1
.5)
a
58
.7
 (3
.5)
71
.4
 (1
.8)
a
70
.1
 (2
.2)
a
 
Fe
m
al
e
53
.0
 (0
.7)
32
.5
 (1
.4)
20
.3
 (1
.5)
41
.3
 (3
.5)
28
.6
 (1
.8)
29
.9
 (2
.2)
A
ge
 (y
ea
rs)
 
12
–1
4
50
.2
 (0
.7)
48
.2
 (1
.5)
45
.5
 (1
.8)
30
.5
 (3
.0)
b
48
 (1
.8)
47
.7
 (2
.2)
 
15
–1
7
49
.8
 (0
.7)
51
.8
 (1
.5)
54
.5
 (1
.8)
69
.5
 (3
.0)
52
 (1
.8)
52
.3
 (2
.2)
R
ac
e/
et
hn
ic
ity
 
N
on
-H
isp
an
ic
 W
hi
te
56
.9
 (0
.8)
68
.9
 (1
.3)
a
71
.3
 (1
.3)
61
.3
 (4
.4)
73
.7
 (1
.4)
a
71
.6
(1.
8)a
 
N
on
-H
isp
an
ic
 B
la
ck
13
.6
 (0
.7)
14
.1
 (1
.0)
13
.0
 (0
.8)
11
.4
 (2
.1)
14
.3
 (1
.1)
15
.8
 (1
.3)
 
A
m
er
ic
an
 In
di
an
/N
at
iv
e 
A
m
er
ic
an
0.
6 
(0.
2)
0.
8 
(0.
2)
0
1.
1(0
.1)
0.
6 
(0.
2)
0.
3 
(0.
4)c
 
A
sia
n
4.
5 
(0.
3)
0.
8 
(0.
3)
2.
5 
(0.
3)
1.
8 
(0.
1)
0.
4 
(0.
1)
0.
3 
(0.
1)
 
O
th
er
2.
9 
(0.
2)
3.
4 
(0.
5)
4.
6 
(0.
8)
2.
4 
(2.
4)
3.
2 
(0.
7)
3.
1 
(0.
7)
 
H
isp
an
ic
21
.5
 (0
.6)
12
.0
 (0
.9)
8.
6 
(0.
8)
22
.0
 (1
.8)
7.
8 
(0.
7)
8.
9 
(0.
9)
Po
v
er
ty
-to
-in
co
m
e 
ra
tio
 
A
t o
r a
bo
v
e 
20
0 
%
62
.3
 (0
.8)
54
.7
 (1
.6)
a
57
.5
 (1
.9)
44
.1
 (1
.9)
b
56
.9
 (2
.0)
b
51
.2
 (2
.2)
b
 
B
el
ow
 2
00
 %
37
.7
 (0
.8)
45
.3
 (1
.6)
42
.5
 (1
.9)
55
.9
 (1
.9)
43
.1
 (2
.0)
48
.8
 (2
.2)
M
at
er
na
l e
du
ca
tio
n
 
≤H
ig
h 
sc
ho
ol
39
.2
 (0
.8)
39
.4
 (1
.8)
29
.4
 (2
.4)
54
.2
 (3
.0)
37
.0
 (2
.3)
44
.3
 (2
.3)
 
>
H
ig
h 
sc
ho
ol
60
.8
 (0
.8)
60
.6
 (1
.8)
70
.6
 (2
.4)
45
.8
 (3
.0)
63
.0
 (2
.3)
55
.7
 (2
.3)
H
ea
lth
ca
re
 in
su
ra
nc
e
 
U
ni
ns
ur
ed
10
.5
 (0
.7)
6.
8 
(1.
2)b
14
.2
 (0
.1)
0.
6 
(0.
01
)a
6.
1 
(1.
1)b
4.
5 
(0.
5)b
 
In
su
re
d
89
.5
 (0
.7)
93
.2
(1.
2)
85
.8
 (0
.1)
99
.4
 (0
.01
)
93
.9
 (1
.1)
95
.5
 (0
.5)
B
irt
hw
ei
gh
t (
g)
 
Le
ss
 th
an
 2
,5
00
8.
8 
(0.
4)
12
.1
 (1
.0)
a
8.
4 
(1.
0)
21
.7
 (3
.3)
b
9.
9 
(1.
0)
11
.1
 (1
.2)
 
G
re
at
er
 th
an
 o
r e
qu
al
 to
 2
,5
00
91
.2
 (0
.4)
87
.9
 (1
.0)
91
.6
 (1
.0)
78
.3
 (3
.3)
90
.1
 (1
.0)
88
.9
 (1
.2)
D
isa
bi
lit
y
Matern Child Health J. Author manuscript; available in PMC 2017 February 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Phillips et al. Page 16
C
hi
ld
re
n
 w
ith
ou
t 
de
v
el
op
m
en
ta
l 
di
sa
bi
lit
ie
s (
N 
= 8
,14
1)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 a
ny
 
le
ar
n
in
g 
an
d 
be
ha
v
io
ra
l d
isa
bi
lit
y 
(N
 = 
1,4
78
)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 
a
u
tis
m
 (N
 = 
93
)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 
in
te
lle
ct
ua
l d
isa
bi
lit
y 
(ID
) w
ith
ou
t a
ut
ism
 (N
 
=
 6
0)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 A
D
H
D
 
w
ith
ou
t a
ut
ism
/ID
 (N
 
=
 8
45
)
%
 (S
E)
C
hi
ld
re
n
 w
ith
 L
D
/
o
th
er
 D
D
 w
ith
ou
t 
A
D
H
D
/a
ut
ism
/ID
 (N
 = 
37
6)
%
 (S
E)
 
A
D
H
D
0
65
.0
(1.
5)
60
.7
 (2
.2)
48
.7
 (3
.6)
10
0 
(0)
0
 
A
ut
ism
0
6.
0 
(0.
7)
10
0 
(0)
0
0
0
 
LD
0
56
.4
 (1
.6)
73
.3
(1.
7)
89
.3
 (0
.7)
42
.3
 (2
.1)
95
.7
(0.
8)
 
ID
0
5.
2 
(0.
7)
23
.4
(1.
9)
10
0 
(0)
0
0
 
O
th
er
 D
D
0
25
.4
 (1
.3)
72
.6
(1.
1)
64
.7
 (2
.1)
11
.4
 (1
.4)
25
.8
(2.
3)
W
ei
gh
te
d 
%
 p
re
se
nt
ed
; S
ta
nd
ar
d 
er
ro
r (
SE
); 
Sta
tis
tic
al 
sig
nif
ic
an
ce
 o
f a
 
P 
<
 .0
01
; b
 
P 
<
.0
5;
 c
R
el
at
iv
e 
st
an
da
rd
 e
rro
r (
RS
E)
 gr
ea
ter
 th
an
 50
 %
 an
d s
ho
uld
 be
 co
ns
ide
red
 to
o u
nre
lia
ble
 fo
r m
os
t p
urp
os
es;
 
Pe
rc
en
t m
iss
in
g:
 m
at
er
na
l e
du
ca
tio
n 
(1 
%)
; p
ov
er
ty
-to
-in
co
m
e 
ra
tio
 (1
2.5
 %
); 
he
alt
hc
are
 in
su
ran
ce
 (<
1 %
); 
bir
thw
eig
ht 
(7.
3 %
); 
ch
ild
 B
M
I (
6 %
)
Matern Child Health J. Author manuscript; available in PMC 2017 February 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Phillips et al. Page 17
Ta
bl
e 
2
Pr
ev
al
en
ce
 a
nd
 u
na
dju
ste
d a
nd
 ad
jus
ted
 pr
eva
le
nc
e 
ra
tio
s f
or
 a
do
le
sc
en
ts 
12
–1
7 
ye
ar
s o
f a
ge
 w
ith
 d
ev
el
op
m
en
ta
l d
isa
bi
lit
ie
s, 
by
 B
M
I-s
ta
tu
s, 
N
H
IS
 2
00
8–
20
10
C
hi
ld
re
n
 w
ith
ou
t 
de
v
el
op
m
en
ta
l 
di
sa
bi
lit
ie
s
C
hi
ld
re
n
 w
ith
 a
ny
 
le
ar
n
in
g 
an
d 
be
ha
v
io
ra
l 
di
sa
bi
lit
y
C
hi
ld
re
n
 w
ith
 a
ut
ism
C
hi
ld
re
n
 w
ith
 in
te
lle
ct
ua
l 
di
sa
bi
lit
y 
(ID
) w
ith
ou
t 
a
u
tis
m
C
hi
ld
re
n
 w
ith
 A
D
H
D
 
w
ith
ou
t a
ut
ism
/ID
C
hi
ld
re
n
 w
ith
 L
D
/o
th
er
 
D
D
 w
ith
ou
t A
D
H
D
/
a
u
tis
m
/ID
U
nd
er
w
ei
gh
t (
< 5
th 
pe
rce
nti
le)
 
Pr
ev
al
en
ce
 (S
E)
3.
5 
(0.
3)
5.
6 
(1)
b
4.
5 
(1.
0)
14
.8
 (0
.9)
b
5.
0 
(1.
3)
6.
0 
(1.
8)
 
U
na
dju
ste
d P
R 
(95
 %
 C
I)
R
ef
1.
6 
(1.
07
–2
.33
)
1.
2 
(0.
41
–3
.55
)
4.
3 
(1.
21
–1
5.1
5)
1.
3 
(0.
77
–2
.27
)
1.
6 
(0.
72
–3
.43
)
 
aP
R
 (9
5 %
 C
I)
R
ef
1.
5 
(1.
01
–2
.27
)
1.
1 
(0.
31
–4
.05
)
1.
5 
(0.
35
–6
.61
)
1.
2 
(0.
71
–2
.18
)
1.
4 
(0.
63
–2
.93
)
O
ve
rw
ei
gh
t (
85
th 
to 
< 9
5th
 pe
rce
nti
le)
 
Pr
ev
al
en
ce
 (S
E)
18
.2
 (0
.6)
17
.5
 (1
.2)
20
.9
 (1
.4)
15
.7
 (3
.8)
18
.0
 (1
.6)
20
.7
 (2
.1)
 
U
na
dju
ste
d P
R 
(95
 %
 C
I)
R
ef
1.
0 
(0.
83
–1
.15
)
1.
2 
(0.
65
–2
.06
)
1.
0 
(0.
42
–2
.52
)
1.
0 
(0.
81
–1
.23
)
1.
2 
(0.
89
–1
.53
)
 
aP
R
 (9
5 %
 C
I)
R
ef
1.
0 
(0.
82
–1
.15
)
1.
2 
(0.
62
–2
.12
)
1.
1 
(0.
49
–2
.58
)
1.
0 
(0.
80
–1
.23
)
1.
2 
(0.
88
–1
.51
)
O
be
se
 (9
5th
 pe
rce
nti
le 
or 
ab
ov
e)
 
Pr
ev
al
en
ce
 (S
E)
13
.1
 (0
.5)
20
.4
 (1
.3)
a
31
.8
 (1
.5)
a
19
.8
 (5
.0)
17
.6
 (1
.4)
b
20
.3
(1.
9)a
 
U
na
dju
ste
d P
R 
(95
 %
 C
I)
R
ef
1.
6 
(1.
34
–1
.82
)
2.
2 
(1.
50
–3
.24
)
1.
5 
(0.
71
–2
.98
)
1.
3 
(1.
04
–1
.53
)
1.
5 
(1.
14
–1
.83
)
 
aP
R
 (9
5 %
 C
I)
R
ef
1.
5 
(1.
25
–1
.75
)
2.
1 
(1.
44
–3
.16
)
1.
4 
(0.
69
–2
.98
)
1.
2 
(0.
98
–1
.51
)
1.
3 
(0.
99
–1
.70
)
A
dju
ste
d f
or 
ch
ild
’s 
ag
e, 
sex
, 
ra
ce
/e
th
ni
ci
ty
,
 
m
o
th
er
’s
 e
du
ca
tio
n,
 p
ov
er
ty
-to
-in
co
m
e 
ra
tio
, a
nd
 b
irt
hw
ei
gh
t
R
ef
: T
he
 re
fe
re
nt
 g
ro
up
 fo
r t
hi
s a
na
ly
sis
 is
 a
ll 
ch
ild
re
n 
no
t i
n 
th
e 
BM
I g
ro
up
 o
f i
nt
er
es
t. 
Su
pp
le
m
en
ta
l a
na
ly
sis
 (d
ata
 no
t s
ho
w
n
) i
n w
hic
h t
he
 re
fer
en
t g
rou
p i
s n
orm
al 
we
igh
t c
hil
dre
n s
ho
w
ed
 si
m
ila
r r
es
ul
ts
SE
 
St
an
da
rd
 e
rro
r, 
CI
 
co
n
fid
en
ce
 in
te
rv
al
, a
PR
 
A
dju
ste
d p
rev
al
en
ce
 ra
tio
a P
 
<
 .0
01
;
b P
 
<
.0
5
Matern Child Health J. Author manuscript; available in PMC 2017 February 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Phillips et al. Page 18
Ta
bl
e 
3
R
isk
 fa
ct
or
s 
fo
r o
be
sit
y 
w
ith
in
 a
do
le
sc
en
ts 
12
–1
7 
ye
ar
s o
f a
ge
 w
ith
ou
t a
nd
 w
ith
 d
ev
el
op
m
en
ta
l d
isa
bi
lit
ie
s, 
by
 d
ev
el
op
m
en
ta
l d
isa
bi
lit
y 
ty
pe
, N
H
IS
, 
20
08
–2
01
0
M
od
el
 in
cl
ud
ed
 th
e 
fo
llo
w
in
g 
fa
ct
or
s
C
hi
ld
re
n
 w
ith
ou
t 
de
v
el
op
m
en
ta
l 
di
sa
bi
lit
ie
s
a
PR
 (9
5 %
 C
I)
C
hi
ld
re
n
 w
ith
 a
ny
 
le
ar
n
in
g 
an
d 
be
ha
v
io
ra
l d
isa
bi
lit
y
a
PR
 (9
5 %
 C
I)
C
hi
ld
re
n
 w
ith
 a
ut
ism
a
PR
 (9
5 %
 C
I)
C
hi
ld
re
n
 w
ith
 
in
te
lle
ct
ua
l d
isa
bi
lit
y 
(ID
) w
ith
ou
t a
ut
ism
a
PR
 (9
5 %
 C
I)
C
hi
ld
re
n
 w
ith
 A
D
H
D
 
w
ith
ou
t a
ut
ism
/ID
a
PR
 (9
5 %
 C
I)
C
hi
ld
re
n
 w
ith
 L
D
/
o
th
er
 D
D
 w
ith
ou
t 
A
D
H
D
/a
ut
ism
/ID
a
PR
 (9
5 %
 C
I)
Se
x
a
 
M
al
e
1.
5 
(1.
30
–1
.77
)
1.
0 
(0.
78
–1
.39
)
1.
1 
(0.
36
–3
.10
)
1.
1 
(0.
40
–3
.23
)
1.
0 
(0.
61
–1
.51
)
1.
2 
(0.
64
–2
.29
)
 
Fe
m
al
e
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
A
ge
 (y
ea
rs)
a
 
12
–1
4
1.
4 
(1.
19
–1
.63
)
1.
0 
(0.
73
–1
.24
)
0.
5 
(0.
25
–1
.10
)
0.
5 
(0.
18
–1
.42
)
1.
0 
(0.
66
–1
.44
)
0.
7 
(0.
43
–1
.25
)
 
15
–1
7
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
R
ac
e/
et
hn
ic
ity
a
 
N
on
-H
isp
an
ic
 b
la
ck
1.
8 
(1.
38
–2
.26
)
1.
3 
(0.
89
–1
.79
)
2.
3 
(1.
27
–4
.13
)
0.
5 
(0.
62
–2
.20
)
1.
3 
(0.
78
–2
.01
)
0.
8 
(0.
41
–1
.64
)
 
A
m
er
ic
an
 In
di
an
/N
at
iv
e 
A
m
er
ic
an
1.
9 
(0.
89
–4
.02
)
2.
6 
(1.
83
–3
.70
)
n
/a
1.
8 
(0.
36
–8
.55
)
3.
0 
(1.
82
–4
.98
)
2.
4 
(1.
01
–5
.70
)
 
A
sia
n
0.
8 
(0.
53
–1
.23
)
0.
9 
(0.
29
–2
.74
)
1.
6 
(0.
66
–4
.08
)
1.
8 
(0.
35
–8
.78
)
3.
0 
(2.
00
–4
.53
)
2.
4 
(1.
23
–4
.65
)
 
O
th
er
1.
6 
(1.
04
–2
.39
)
1.
5 
(0.
82
–2
.57
)
0.
4 
(0.
06
–2
.46
)
1.
8 
(0.
36
–8
.55
)
2.
0 
(0.
99
–3
.93
)
0.
7 
(0.
19
–2
.59
)
 
H
isp
an
ic
1.
6 
(1.
26
–1
.90
)
1.
2 
(0.
85
–1
.66
)
0.
5 
(0.
11
–2
.40
)
1.
2 
(0.
62
–2
.20
)
1.
2 
(0.
70
–1
.96
)
1.
2 
(0.
64
–2
.30
)
 
N
on
-H
isp
an
ic
 W
hi
te
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
M
at
er
na
l E
du
ca
tio
na
 
H
ig
h 
sc
ho
ol
 o
r l
es
s
0.
7 
(0.
57
–0
.83
)
1.
0 
(0.
78
–1
.37
)
0.
5 
(0.
29
–1
.00
)
1.
9 
(0.
74
–4
.90
)
1.
1 
(0.
76
–1
.60
)
1.
4 
(0.
85
–2
.43
)
 
B
ey
on
d 
hi
gh
 sc
ho
ol
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
Po
v
er
ty
-to
-in
co
m
e 
ra
tio
a
 
B
el
ow
 2
00
 %
1.
2 
(0.
98
–1
.45
)
1.
4 
(1.
08
–1
.94
)
0.
6 
(0.
30
–1
.24
)
3.
7 
(1.
12
–1
2.2
5)
1.
5 
(1.
01
–2
.28
)
2.
5 
(1.
46
–4
.42
)
 
A
t o
r a
bo
v
e 
20
0 
%
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
B
irt
hw
ei
gh
ta
 
Le
ss
 th
an
 2
,5
00
 g
1.
0 
(0.
76
–1
.26
)
1.
4 
(0.
97
–1
.96
)
2.
7 
(1.
54
–4
.76
)
2.
4 
(0.
95
–6
.03
)
1.
0 
(0.
55
–1
.92
)
1.
6 
(0.
77
–3
.53
)
 
G
re
at
er
 th
an
 o
r e
qu
al
 to
 2
,5
00
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
aP
R 
A
dju
ste
d p
rev
al
en
ce
 ra
tio
, C
I c
o
n
fid
en
ce
 in
te
rv
al
a P
re
v
al
en
ce
 ra
tio
 is
 a
dju
ste
d f
or 
ch
ild
’s 
ag
e, 
sex
, 
ra
ce
/e
th
ni
ci
ty
,
 
m
o
th
er
’s
 e
du
ca
tio
n,
 p
ov
er
ty
-to
-in
co
m
e 
ra
tio
, a
nd
 b
irt
hw
ei
gh
t
Matern Child Health J. Author manuscript; available in PMC 2017 February 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Phillips et al. Page 19
Table 4
Concurrent medical conditions among non-obese and obese adolescents 12–17 years of age with 
developmental disabilities, NHIS 2008–2010
Medical conditions Obese children 
without DDs versus 
non-obese children 
without DDs (Risk 
associated with obesity 
in the absence of DDs)
aPR (95 % CI)
Non-obese children 
with DDs versus non-
obese children without 
DDs (Risk associated 
with having a DD in the 
absence of obesity)
aPR (95 % CI)
Obese children with 
DDs versus non-obese 
children with DDs 
(Additional risk 
associated with obesity 
among children who 
have a DD)
aPR (95 % CI)
Obese children with 
DDs versus obese 
children without DDs 
(Additional risk 
associated with having 
a DD among children 
who are obese)
aPR (95 % CI)
Asthma (ever) 1.27 (1.07–1.50) 1.56 (1.21–2.01) 1.50 (1.12–2.02) 1.36 (1.13–1.63)
Any respiratory allergy (last 12 
m)
1.07 (0.85–1.35) 1.53 (1.12–2.08) 1.29 (0.94–1.76) 1.28 (1.06–1.55)
Head/chest cold (past 2 weeks) 1.22 (0.98–1.52) 1.22 (0.87–1.70) 1.16 (0.84–1.61) 1.34 (1.10–1.63)
Eczema/skin allergy (last 12 
m)
1.41 (1.14–1.74) 1.41 (1.05–1.91) 1.32 (0.96–1.80) 1.56 (1.29–1.88)
Food/digestive allergy (last 12 
m)
1.04 (0.74–1.47) 1.10 (0.67–1.82) 0.68 (0.37–1.25) 1.51 (1.14–2.00)
Stomach/intestinal illness w/
vomiting or diarrhea (past 2 
weeks)
1.19 (0.86–1.64) 1.40 (0.92–2.12) 1.08 (0.70–1.67) 1.64 (1.29–2.08)
Frequent severe headaches/
migraines (last 12 m)
1.37 (1.10–1.69) 1.71 (1.33–2.20) 1.38 (1.00–1.90) 1.60 (1.32–1.94)
Prevalence ratio is adjusted for child’s age, sex, race/ethnicity, mother’s education, poverty-to-income ratio, and birthweight
aPR Adjusted prevalence ratio, CI confidence interval
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